Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 53

Cited In for PubMed (Select 11103776)

1.

DNA methylation and apoptosis resistance in cancer cells.

Hervouet E, Cheray M, Vallette FM, Cartron PF.

Cells. 2013 Jul 18;2(3):545-73. doi: 10.3390/cells2030545.

2.

A dual role for the histone methyltransferase PR-SET7/SETD8 and histone H4 lysine 20 monomethylation in the local regulation of RNA polymerase II pausing.

Kapoor-Vazirani P, Vertino PM.

J Biol Chem. 2014 Mar 14;289(11):7425-37. doi: 10.1074/jbc.M113.520783. Epub 2014 Jan 23.

3.

Promyelocytic leukemia protein interacts with the apoptosis-associated speck-like protein to limit inflammasome activation.

Dowling JK, Becker CE, Bourke NM, Corr SC, Connolly DJ, Quinn SR, Pandolfi PP, Mansell A, O'Neill LA.

J Biol Chem. 2014 Mar 7;289(10):6429-37. doi: 10.1074/jbc.M113.539692. Epub 2014 Jan 9.

4.

AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC.

Sagulenko V, Thygesen SJ, Sester DP, Idris A, Cridland JA, Vajjhala PR, Roberts TL, Schroder K, Vince JE, Hill JM, Silke J, Stacey KJ.

Cell Death Differ. 2013 Sep;20(9):1149-60. doi: 10.1038/cdd.2013.37. Epub 2013 May 3.

5.

Restoration of ASC expression sensitizes colorectal cancer cells to genotoxic stress-induced caspase-independent cell death.

Hong S, Hwang I, Lee YS, Park S, Lee WK, Fernandes-Alnemri T, Alnemri ES, Kim YS, Yu JW.

Cancer Lett. 2013 May 1;331(2):183-91. doi: 10.1016/j.canlet.2012.12.020. Epub 2013 Jan 12.

6.

Tissue-specific opposing functions of the inflammasome adaptor ASC in the regulation of epithelial skin carcinogenesis.

Drexler SK, Bonsignore L, Masin M, Tardivel A, Jackstadt R, Hermeking H, Schneider P, Gross O, Tschopp J, Yazdi AS.

Proc Natl Acad Sci U S A. 2012 Nov 6;109(45):18384-9. doi: 10.1073/pnas.1209171109. Epub 2012 Oct 22.

7.

Dual role of apoptosis-associated speck-like protein containing a CARD (ASC) in tumorigenesis of human melanoma.

Liu W, Luo Y, Dunn JH, Norris DA, Dinarello CA, Fujita M.

J Invest Dermatol. 2013 Feb;133(2):518-27. doi: 10.1038/jid.2012.317. Epub 2012 Aug 30.

8.

Redefining the impact of nutrition on breast cancer incidence: is epigenetics involved?

Teegarden D, Romieu I, Lelièvre SA.

Nutr Res Rev. 2012 Jun;25(1):68-95. doi: 10.1017/S0954422411000199. Review.

9.

Detection of TIMP3 promoter hypermethylation in salivary rinse as an independent predictor of local recurrence-free survival in head and neck cancer.

Sun W, Zaboli D, Wang H, Liu Y, Arnaoutakis D, Khan T, Khan Z, Koch WM, Califano JA.

Clin Cancer Res. 2012 Feb 15;18(4):1082-91. doi: 10.1158/1078-0432.CCR-11-2392. Epub 2012 Jan 6.

10.

Aberrant promoter CpG methylation and its translational applications in breast cancer.

Xiang TX, Yuan Y, Li LL, Wang ZH, Dan LY, Chen Y, Ren GS, Tao Q.

Chin J Cancer. 2013 Jan;32(1):12-20. doi: 10.5732/cjc.011.10344. Epub 2011 Nov 4. Review.

11.

Caspase-1 protein induces apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC)-mediated necrosis independently of its catalytic activity.

Motani K, Kushiyama H, Imamura R, Kinoshita T, Nishiuchi T, Suda T.

J Biol Chem. 2011 Sep 30;286(39):33963-72. doi: 10.1074/jbc.M111.286823. Epub 2011 Aug 8.

12.

Structural and functional profiling of the human histone methyltransferase SMYD3.

Foreman KW, Brown M, Park F, Emtage S, Harriss J, Das C, Zhu L, Crew A, Arnold L, Shaaban S, Tucker P.

PLoS One. 2011;6(7):e22290. doi: 10.1371/journal.pone.0022290. Epub 2011 Jul 14.

13.

An epigenetic marker panel for detection of lung cancer using cell-free serum DNA.

Begum S, Brait M, Dasgupta S, Ostrow KL, Zahurak M, Carvalho AL, Califano JA, Goodman SN, Westra WH, Hoque MO, Sidransky D.

Clin Cancer Res. 2011 Jul 1;17(13):4494-503. doi: 10.1158/1078-0432.CCR-10-3436. Epub 2011 May 24.

14.

The NLR adaptor ASC/PYCARD regulates DUSP10, mitogen-activated protein kinase (MAPK), and chemokine induction independent of the inflammasome.

Taxman DJ, Holley-Guthrie EA, Huang MT, Moore CB, Bergstralh DT, Allen IC, Lei Y, Gris D, Ting JP.

J Biol Chem. 2011 Jun 3;286(22):19605-16. doi: 10.1074/jbc.M111.221077. Epub 2011 Apr 12.

15.

Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer.

Sproul D, Nestor C, Culley J, Dickson JH, Dixon JM, Harrison DJ, Meehan RR, Sims AH, Ramsahoye BH.

Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4364-9. doi: 10.1073/pnas.1013224108. Epub 2011 Feb 28.

16.
17.

SUV420H2-mediated H4K20 trimethylation enforces RNA polymerase II promoter-proximal pausing by blocking hMOF-dependent H4K16 acetylation.

Kapoor-Vazirani P, Kagey JD, Vertino PM.

Mol Cell Biol. 2011 Apr;31(8):1594-609. doi: 10.1128/MCB.00524-10. Epub 2011 Feb 14.

18.

Genomic profiling of C/EBPβ2 transformed mammary epithelial cells: a role for nuclear interleukin-1β.

Russell A, Boone B, Jiang A, Sealy L.

Cancer Biol Ther. 2010 Sep 1;10(5):509-19. doi: 10.4161/cbt.10.5.12725. Epub 2010 Sep 21.

19.

Quantitative analysis of promoter methylation in exfoliated epithelial cells isolated from breast milk of healthy women.

Wong CM, Anderton DL, Smith-Schneider S, Wing MA, Greven MC, Arcaro KF.

Epigenetics. 2010 Oct 1;5(7):645-55. doi: 10.4161/epi.5.7.12961. Epub 2010 Oct 1.

20.

Molecular analysis of plasma DNA for the early detection of lung cancer by quantitative methylation-specific PCR.

Ostrow KL, Hoque MO, Loyo M, Brait M, Greenberg A, Siegfried JM, Grandis JR, Gaither Davis A, Bigbee WL, Rom W, Sidransky D.

Clin Cancer Res. 2010 Jul 1;16(13):3463-72. doi: 10.1158/1078-0432.CCR-09-3304. Epub 2010 Jun 30.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk